Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing to chemotherapy and targeted therapy in liver hepatocellular carcinomaYitong Pan(Central South University), Xinhui Tang(Central South University)AgingMay 22, 202410.18632/aging.205855Cited by 5SaveCiteExport RISWatch citationsRelated PapersLactate Promotes Hypoxic Granulosa Cells’ Autophagy by Activating the HIF-1α/BNIP3/Beclin-1 Signaling Axis|Genes|2024|8